Apollomics (APLM) Common Equity (2020 - 2025)

Apollomics (APLM) has 5 years of Common Equity data on file, last reported at $3.2 million in Q4 2025.

• Common Equity for Q4 2025 came in at $3.2 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $3.2 million (changed N/A YoY), and the FY2025 annual result was $3.2 million, changed N/A from the prior year.
• Common Equity eased to $3.2 million in Q4 2025 per APLM's latest filing, from $55.7 million in the prior quarter.
• Over five years, Common Equity peaked at $55.7 million in Q2 2023 and troughed at -$448.1 million in Q4 2022.
• A 4-year average of -$150.5 million and a median of -$104.8 million in 2021 frame the typical range for Common Equity.
• The sharpest annual moves came in 2021 and 2022: Common Equity plunged 66.39% in 2021, then plunged 110.52% in 2022.
• A 4-year view of Common Equity shows it stood at -$212.9 million in 2021, then sank by 110.52% to -$448.1 million in 2022, then surged by 112.43% to $55.7 million in 2023, then sank by 94.28% to $3.2 million in 2025.
• Business Quant data shows APLM's Common Equity at $3.2 million in Q4 2025, $55.7 million in Q2 2023, and -$448.1 million in Q4 2022.